SkinHealth Systems Inc. (SKIN) stock price, financials & research

Regular session · ET · Market data may be delayed.

GoAI snapshot

Jul 10, 2026

38/ 100

GoAI Score

Sell

Valuation

47

Fair Value

Sentiment

52

Mixed

Risk

69

High Risk

Momentum

36

Weakening

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

Company profile

Company website

SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.

Industry: Medical - Specialties
Sector: Healthcare
Headquarters: US
CEO: Pedro Malha
Listed since: Nov 24, 2020
Employees: 613

Market position

Day range

Current $0.7001

$0.6621$0.7099

52-week range

Current $0.7001

$0.551$2.69

Open: $0.7081
Previous close: $0.70
Volume: 226.97K; 0.11× average
Average volume: 2.05M; Average daily volume
Market cap: 90.73M USD
Beta: 1; Market reference 1
50-day average: $0.7311; -4.23% below average
200-day average: $0.9847; -28.90% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 321.67M USD
P/E (TTM): -3.1×
P/B (TTM): 1.63×
P/S (TTM): 0.31×
EV / EBITDA: 8.3×
Earnings yield: -5.42%
Free cash flow yield: 18.40%
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 66.34%
Operating margin: -1.49%
Net margin: -9.79%
Return on equity: -15.58%
Return on assets: -1.90%
Return on invested capital: -4.70%

Financial health

Debt / equity: 6.6×
Current ratio: 1.66×
Altman Z-score: -0.47
Piotroski F-score: 5 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

300.79M USD-10.02%

Operating income

−20.8M USD+69.31%

Net income

−9.52M USD+67.29%

Financial statements: Income statement
Metric (USD)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	300.79M USD	334.29M USD	397.99M USD	365.88M USD	260.09M USD
Cost of goods sold	104.43M USD	152M USD	242.88M USD	117.1M USD	81.55M USD
Gross profit	196.36M USD	182.3M USD	155.11M USD	248.78M USD	178.54M USD
Research and development	5.63M USD	6.3M USD	10.1M USD	8.44M USD	8.2M USD
Selling, general, and administrative	211.54M USD	243.77M USD	275.93M USD	266.18M USD	210.27M USD
Operating expenses	217.17M USD	250.07M USD	286.03M USD	274.62M USD	218.47M USD
Interest income	8.95M USD	16.64M USD	23.17M USD	9.18M USD	39K USD
Interest expense	19.33M USD	10.41M USD	13.65M USD	13.39M USD	11.78M USD
Depreciation and amortization	25.35M USD	29.48M USD	34.68M USD	22.87M USD	17.93M USD
Operating income	−20.8M USD	−67.77M USD	−130.92M USD	−25.84M USD	−39.93M USD
Net income	−9.52M USD	−29.1M USD	−100.12M USD	44.22M USD	−378.76M USD

Company facts updated Sep 15, 2026.

Earnings

EPS beat rate: 73%; 8 beats, 3 misses, 0 met estimates
Average EPS surprise: +34.49%; 11 comparable reports
Latest EPS result: -0.02; Estimate -0.03 · Beat by 20.00%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$1.50

114.26% upside

Past 12 months12-month forecastHigh $2.00Average $1.50Low $1.00

Rating distribution

14 ratings

Strong buy00%

Buy429%

Hold750%

Sell321%

Strong sell00%

Recent analyst actions

11 institutions

Roth CapitalmaintainBuyMay 20, 2026

JefferiesdowngradeBuyHoldNov 15, 2023

William BlairdowngradeOutperformMarket PerformNov 14, 2023

SKIN news

globenewswire.comSep 8, 2026

Hydrafacial Expands Treatment Personalization and Elevates Results with Two New Treatment Enhancers

LONG BEACH, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems (Nasdaq: SKIN), home to Hydrafacial, today announced the launch of two new Hydrafacial Treatment Enhancers: HydraGlow Pre-Extraction Peel and…

Read source

globenewswire.comAug 26, 2026

SkinHealth Systems Launches Hydrafacial Impact to Help Providers Accelerate Practice Growth

National nine-city education series expands Hydrafacial's industry-leading provider training platform National nine-city education series expands Hydrafacial's industry-leading provider training platform

Read source

zacks.comAug 11, 2026

SkinHealth Systems Inc. (SKIN) International Revenue Performance Explored

Examine the evolution of SkinHealth Systems Inc.'s (SKIN) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

Read source

defenseworld.netAug 11, 2026

Herbalife (NYSE:HLF) versus Beauty Health (NASDAQ:SKIN) Head to Head Comparison

Herbalife (NYSE: HLF - Get Free Report) and Beauty Health (NASDAQ: SKIN - Get Free Report) are both small-cap consumer staples companies, but which is the superior investment? We will compare the two businesses based on…

Read source

seekingalpha.comAug 7, 2026

SkinHealth Systems Inc. (SKIN) Q2 2026 Earnings Call Transcript

Read source

marketbeat.comAug 7, 2026

Beauty Health Q2 Earnings Call Highlights

Beauty Health NASDAQ: SKIN reported second-quarter revenue at the low end of its guidance range as cautious capital spending by providers continued to weigh on equipment sales, while stronger gross margins and expense…

Read source